Reuters logo
5 months ago
BRIEF-Clearside Biomedical says first patient randomized in phase 3 clinical trial of Zuprata
February 16, 2017 / 12:45 PM / 5 months ago

BRIEF-Clearside Biomedical says first patient randomized in phase 3 clinical trial of Zuprata

1 Min Read

Feb 16 (Reuters) - Clearside Biomedical Inc

* Clearside Biomedical Inc announces first patient randomized in phase 3 clinical trial of Zuprata used together with Eylea in subjects with retinal vein occlusion

* Says Clearside anticipates total enrollment of approximately 460 patients in trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below